Other Information.
−Removed: Effective February 9, 2021, the Company filed
−Removed: a Certificate of Amendment to the Company’s Articles of Incorporation with the Secretary of State of Nevada to increase the authorized
−Removed: amount of common stock from 1,500,000,000 to 2,500,000,000, without changing the par value of the common stock or authorized number and
−Removed: par value of “blank check”
−Removed: Preferred Stock.
−Removed: Certificate of Amendment to the Articles of Incorporation filed with the Secretary of State of Nevada on February 10, 2021, effective February 9, 2021.
−Removed: (Filed as an exhibit to the Registrant’s Form 10-Q filed on March 17, 2021 and incorporated by reference herein)
−Removed: Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Executive Officer
−Removed: Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Financial and Accounting Officer
−Removed: Section 1350 Certification of Principal Executive Officer
−Removed: Section 1350 Certification of Principal Financial and Accounting Officer
−Removed: XBRL Instance Document
−Removed: XBRL Taxonomy Extension Schema Document
−Removed: XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: XBRL Taxonomy Extension Labels Linkbase Document
−Removed: XBRL Taxonomy Extension Definition Linkbase Document
−Removed: XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: Filed herewith.
−Removed: Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability under those sections.
−Removed: Pursuant to the requirements of Section 13 or
−Removed: 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
−Removed: thereunto duly authorized.
−Removed: ORGANICELL REGENERATIVE MEDICINE, INC.
−Removed: /s/ ALBERT MITRANI
+Added: 13(a)-14(a)/15(d)-14(a) Certification of Principal Executive Officer
+Added: 13(a)-14(a)/15(d)-14(a) Certification of Principal Financial and Accounting Officer
+Added: 1350 Certification of Principal Executive Officer
+Added: 1350 Certification of Principal Financial and Accounting Officer
+Added: Instance Document
+Added: Taxonomy Extension Schema Document
+Added: Taxonomy Extension Calculation Linkbase Document
+Added: Taxonomy Extension Labels Linkbase Document
+Added: Taxonomy Extension Definition Linkbase Document
+Added: Taxonomy Extension Presentation Linkbase Document
+Added: to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus
+Added: for purposes of Sections 11 or 12 of the Securities Act of 1933, deemed not filed for purposes of Section 18 of the Securities Exchange
+Added: Act of 1934 and otherwise are not subject to liability under those sections.
+Added: to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
+Added: on its behalf by the undersigned, thereunto duly authorized.
+Added: REGENERATIVE MEDICINE, INC.
ALBERT MITRANI
−Removed: Chief Executive Officer
−Removed: (Principal Executive Officer)
−Removed: June 14, 2021
−Removed: Chief Financial Officer
−Removed: (Principal Financial and Accounting Officer)
−Removed: June 14, 2021
+Added: Executive Officer
+Added: Executive Officer)
+Added: Financial Officer
+Added: Financial and Accounting Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.